Nowadays, gold compounds occupy a relevant position constituting a promising class of
experimental anticancer metallodrugs. Several research efforts have been devoted to the …

A panel of four novel gold (I) complexes, inspired by the clinically established gold drug
auranofin (1-Thio-β-D-glucopyranosatotriethylphosphine gold-2, 3, 4, 6-tetraacetate), was …

Gold complexes have been explored as metallodrugs with great potential applications as
antitumoral agents. In particular, gold-phosphine derivatives seemed quite promising since …

Nowadays, gold compounds constitute a family of very promising experimental agents for
cancer treatment. Indeed, several gold (I) and gold (III) compounds were shown to manifest …

A group of triethylphosphine gold (I) and silver (I) complexes, structurally related to
auranofin, were prepared and investigated as potential anticancer drug candidates. The …

Metal complexes have shown interesting preclinical and clinical results as antitumor drugs
and platinum compounds are well established in current cancer chemotherapy. However …

Gold phosphine complexes, such as auranofin, have been recognized for decades as
antirheumatic agents. Clinical trials are now underway to validate their use in anticancer or …

Well known for their clinical anti-arthritic properties, gold-based drugs have also attracted
interest as potential antitumor agents with gold (I) phosphine derivatives being among the …

A novel gold (I) complex inspired by the known medicinal inorganic compounds auranofin
and thimerosal, namely ethylthiosalicylate (triethylphosphine) gold (I)(AFETT hereafter), was …

Aubipyc, ie [(bipydmb-H) Au (OH)][PF6](where bipydmb-H= deprotonated 6-(1, 1-
dimethylbenzyl)-2, 2′-bipyridine), Auoxo6, ie [(bipy2Me) 2Au2 (μ-O) 2][PF6] 2 (where …